Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. (Q51827780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

main subject

Italy

0 references

cervix uterine cancer

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sara Boveri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Markus Schmitt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Mario Sideri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Paolo Cristoforoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chiara Casadio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sarah Igidbashian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Tarik Gheit

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Massimo Tommasino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

27 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

A30-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Epidemiologic classification of human papillomavirus types associated with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Human papillomavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Human papillomavirus typing of invasive cervical cancers in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Development and duration of human papillomavirus lesions, after initial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.028

10.1016/J.VACCINE.2008.12.028

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19480958%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference